Chemokine networks and breast cancer metastasis

Breast Disease

Volumn 26, Issue 1, 2006, Pages 75-85

  Karnoub, Antoine E ^a   Weinberg, Robert A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Chemokine; Homing; Metastasis; Motility; Recruitment; Stroma

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; INTERLEUKIN 8 ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; PROTEIN ANTIBODY; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; DRUG POTENCY; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; METASTASIS; MICROENVIRONMENT; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FAMILY; REVIEW; STROMA; TUMOR GROWTH;

EID: 34247468926     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2007-26107     Document Type: Review

References (98)

1. C. Akekawatchai, J.D. Holland, M. Kochetkova, J.C. Wallace and S.R. McColl, Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells, J Biol Chem 280 (2005), 39701-39708.
2. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison and M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA 100 (2003), 3983-3988.
3. M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti-Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, S. Schnitt, W.R. Sellers and K. Polyak, Molecular characterization of the tumor microenvironment in breast cancer, Cancer Cell 6 (2004), 17-32.
4. F. Andre, N. Cabioglu, H. Assi, J.C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J.P. Spano, C. Combadiere, C. Bucana, J.C. Soria and M. Cristofanilli, Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer, Ann Oncol 17 (2006), 945-951.
5. D.A. Arenberg, S.L. Kunkel, P.J. Polverini, S.B. Morris, M.D. Burdick, M.C. Glass, D.T. Taub, M.D. Iannettoni, R.I. Whyte and R.M. Strieter, Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases, J Exp Med 184 (1996), 981-992.
6. E. Azenshtein, G. Luboshits, S. Shina, E. Neumark, D. Shahbazian, M. Weil, N. Wigler, I. Keydar and A. Ben-Baruch, The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity, Cancer Res 62 (2002), 1093-1102.
7. R.E. Bachelder, M.A. Wendt and A.M. Mercurio, Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4, Cancer Res 62 (2002), 7203-7206.
8. M. Baggiolini, B. Dewald and B. Moser, Human chemokines: An update, Annu Rev Immunol 15 (1997), 675-705.
9. F. Balkwill, Cancer and the chemokine network, Nat Rev Cancer 4 (2004), 540-550.
10. F. Balkwill and A. Mantovani, Inflammation and cancer: Back to Virchow? Lancet 357 (2001), 539-545.
11. D. Bell, P. Chomarat, D. Broyles, G. Netto, G.M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K.A. Palucka and J. Banchereau, In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas, J Exp Med 190 (1999), 1417-426.
12. D. Belotti, P. Paganoni, L. Manenti, A. Garofalo, S. Marchini, G. Taraboletti and R. Giavazzi, Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation, Cancer Res 63 (2003), 5224-5229.
13. I.H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P.B. Vermeulen and L.Y. Dirix, Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival, Clin Cancer Res 10 (2004), 7157-7162.
14. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek and T. Kirchner, Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression, Nat Rev Cancer 5 (2005), 744-749.
15. M. Burger, J.A. Burger, R.C. Hoch, Z. Oades, H. Takamori and I.U. Schraufstatter, Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor, J Immunol 163 (1999), 2017-2022.
16. N. Cabioglu, J. Summy, C. Miller, N.U. Parikh, A.A. Sahin, S. Tuzlali, K. Pumiglia, G.E. Gallick and J.E. Price, CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation, Cancer Res 65 (2005), 6493-6497.
17. N. Cabioglu, M.S. Yazici, B. Arun, K.R. Broglio, G.N. Hortobagyi, J.E. Price and A. Sahin, CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer, Clin Cancer Res 11 (2005), 5686-5693.
18. A.F. Chambers, A.C. Groom and I.C. MacDonald, Dissemination and growth of cancer cells in metastatic sites, Nat Rev Cancer 2 (2002), 563-572.
19. L.M. Coussens and Z. Werb, Inflammation and cancer, Nature 420 (2002), 860-867.
20. P. Dhawan and A. Richmond, Role of CXCL1 in tumorigenesis of melanoma, J Leukoc Biol 72 (2002), 9-18.
21. H.F. Dvorak, L.F. Brown, M. Detmar and A.M. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol 146 (1995), 1029-1039.
22. A.Z. Fernandis, A. Prasad, H. Band, R. Klosel and R.K. Ganju, Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells, Oncogene 23 (2004), 157-167.
23. I.J. Fidler, The organ microenvironment and cancer metastasis, Differentiation 70 (2002), 498-505.
24. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Again, S.W. Leung, R.D. Koos and G.L. Semenza, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol Cell Biol 16 (1996), 4604-4613.
25. P. Friedl and K. Wolf, Proteolytic and non-proteolytic migration of tumour cells and leucocytes, Biochem Soc Symp (2003), 277-285.
26. S.K. Gupta, P.G. Lysko, K. Pillarisetti, E. Ohlstein and J.M. Stadel, Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines, J Biol Chem 273 (1998), 4282-4287.
27. J. Heidemann, H. Ogawa, M.B. Dwinell, P. Rafiee, C. Maaser, H.R. Gockel, M.F. Otterson, D.M. Ota, N. Lugering, W. Domschke and D.G. Binion, Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2, J Biol Chem 278 (2003), 8508-8515.
28. G. Helbig, K.W. Christopherson, 2nd, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K.D. Miller, H.E. Broxmeyer and H. Nakshatri, NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4, J Biol Chem 278 (2003), 21631-21638.
29. R. Horuk, Chemokine receptors, Cytokine Growth Factor Rev 12 (2001), 313-335.
30. Y. Ino, M. Gotoh, M. Sakamoto, K. Tsukagoshi and S. Hirohashi, Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis, Proc Natl Acad Sci USA 99 (2002), 365-370.
31. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal and M.J. Thun, Cancer statistics, CA Cancer J Clin 56 (2006), 106-130.
32. Z. Johnson, C.A. Power, C. Weiss, F. Rintelen, H. Ji, T. Ruckle, M. Camps, T.N. Wells, M.K. Schwarz, A.E. Proudfoot and C. Rommel, Chemokine inhibition - why, when, where, which and how? Biochem Soc Trans 32 (2004), 366-377.
33. M. Juremalm and G. Nilsson, Chemokine receptor expression by mast cells, Chem Immunol Allergy 87 (2005), 130-144.
34. H. Kang, G. Watkins, A. Douglas-Jones, R.E. Mansel and W.G. Jiang, The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer, Breast 14 (2005), 360-367.
35. H. Kang, G. Watkins, C. Parr, A. Douglas-Jones, R.E. Mansel and W.G. Jiang, Stromal cell derived factor-1: Its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer, Breast Cancer Res 7 (2005), R402-R410.
36. K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, T. Manabe, K. Inaba, N. Minato, M. Oshima and M.M. Taketo, Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes, Cancer Res 64 (2004), 4010-4017.
37. H. Kawashima, N. Watanabe, M. Hirose, X. Sun, K. Atarashi, T. Kimura, K. Shikata, M. Matsuda, D. Ogawa, R. Heljasvaara, M. Rehn, T. Pihlajaniemi and M. Miyasaka, Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1, J Biol Chem 278 (2003), 13069-13076.
38. C. Kieda, How endothelial cell organo-specificity mediates circulating cell homing, Arch Immunol Ther Exp (Warsz) 51 (2003), 81-89.
39. T.F. Kimsey, A.S. Campbell, D. Albo, M. Wilson and T.N. Wang, Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion, Cancer J 10 (2004), 374-380.
40. L. Kopfstein and G. Christofori, Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment, Cell Mol Life Sci 63 (2006), 449-468.
41. E.K. Lau, S. Allen, A.R. Hsu and T.M. Handel, Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins, Adv Protein Chem 68 (2004), 351-391.
42. A. Lebrecht, C. Grimm, T. Lantzsch, E. Ludwig, L. Hefler, E. Ulbrich and H. Koelbl, Monocyte chemoattractant protein-1 serum levels in patients with breast cancer, Tumour Biol 25 (2004), 14-17.
43. T. Lechertier, M. Berard, R. Vassy, M.A. Herve and M. Crepin, Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-1alpha-CXCR4 complexes, Anticancer Res 24 (2004), 4011-4017.
44. B.C. Lee, T.H. Lee, S. Avraham and H.K. Avraham, Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells, Mol Cancer Res 2 (2004), 327-338.
45. S.P. Leong, B. Cady, D.M. Jablons, J. Garcia-Aguilar, D. Reintgen, J. Jakub, S. Pendas, L. Duhaime, R. Cassell, M. Gardner, R. Giuliano, V. Archie, D. Calvin, L. Mensha, S. Shivers, C. Cox, J.A. Werner, Y. Kitagawa and M. Kitajima, Clinical patterns of metastasis, Cancer Metastasis Rev 25 (2006), 221-232.
46. Y.M. Li, Y. Pan, Y. Wei, X. Cheng, B.P. Zhou, M. Tan, X. Zhou, W. Xia, G.N. Hortobagyi, D. Yu and M.C. Hung, Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis, Cancer Cell 6 (2004), 459-469.
47. Z. Liang, T. Wu, H. Lou, X. Yu, R.S. Taichman, S.K. Lau, S. Nie, J. Umbreit and H. Shim, Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4, Cancer Res 64 (2004), 4302-4308.
48. E.Y. Lin, A.V. Nguyen, R.G. Russell and J.W. Pollard, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J Exp Med 193 (2001), 727-740.
49. G. Luboshits, S. Shina, O. Kaplan, S. Engelberg, D. Nass, B. Lifshitz-Mercer, S. Chaitchik, I. Keydar and A. Ben-Baruch, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma, Cancer Res 59 (1999), 4681-4687.
50. C.R. Mackay, Chemokines: Immunology's high impact factors, Nat Immunol 2 (2001), 95-101.
51. S. Manes, E. Mira, C. Gomez-Mouton, R.A. Lacalle, P. Keller, J.P. Labrador and A.C. Martinez, Membrane raft microdomains mediate front-rear polarity in migrating cells, Embo J 18 (1999), 6211-6220.
52. F. Marra, Chemokines in liver inflammation and fibrosis, Front Biosci 7 (2002), d1899-d1914.
53. E. Mira, R.A. Lacalle, M.A. Gonzalez, C. Gomez-Mouton, J.L. Abad, A. Bernad, A.C. Martinez and S. Manes, A role for chemokine receptor transactivation in growth factor signaling, EMBO Rep 2 (2001), 151-156.
54. J.P. Moore, A. Trkola and T. Dragic, Co-receptors for HIV-1 entry, Curr Opin Immunol 9 (1997), 551-562.
55. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verastegui and A. Zlotnik, Involvement of chemokine receptors in breast cancer metastasis, Nature 410 (2001), 50-56.
56. D. Nagakubo, T. Murai, T. Tanaka, T. Usui, M. Matsumoto, K. Sekiguchi and M. Miyasaka, A high endothelial venule secretory protein, mac25/ angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines, J Immunol 171 (2003), 553-561.
57. J.S. Nam, M.J. Kang, A.M. Suchar, T. Shimamura, E.A. Kohn, A.M. Michalowska, V.C. Jordan, S. Hirohashi and L.M. Wakefield, Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells, Cancer Res 66 (2006), 7176-7184.
58. Y. Niwa, H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki and A. Abe, Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer, Clin Cancer Res 7 (2001), 285-289.
59. J.J. Onuffer and R. Horuk, Chemokines, chemokine receptors and small-molecule antagonists: Recent developments, Trends Pharmacol Sci 23 (2002), 459-467.
60. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson and R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell 121 (2005), 335-348.
61. A. Orimo and R.A. Weinberg, Stromal fibroblasts in cancer: A novel tumor-promoting cell type, Cell Cycle 5 (2006), 1597-1601.
62. J.L. Owen, D.M. Lopez, J.F. Grosso, K.M. Guthrie, L.M. Herbert, M. Torroella-Kouri and V. Iragavarapu-Charyulu, The expression of CCL2 by T lymphocytes of mammary tumor bearers: Role of tumor-derived factors, Cell Immunol 235 (2005), 122-135.
63. S. Paget, The distribution of secondary growths in cancer of the breast, Cancer Metastasis Rev 8 (1989), 98-101.
64. A.J. Pelletier, L.J. van der Laan, P. Hildbrand, M.A. Siani, D.A. Thompson, P.E. Dawson, B.E. Torbett and D.R. Salomon, Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells, Blood 96 (2000), 2682-2690.
65. L. Peng, S. Shu and J.C. Krauss, Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells, Cancer Res 57 (1997), 4849-4854.
66. J.W. Pollard, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer 4 (2004), 71-78.
67. S.J. Prest, R.C. Rees, C. Murdoch, J.F. Marshall, P.A. Cooper, M. Bibby, G. Li and S.A. Ali, Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials, Clin Exp Metastasis 17 (1999), 389-396.
68. A.E. Proudfoot, R. Buser, F. Borlat, S. Alouani, D. Soler, R.E. Offord, J.M. Schroder, C.A. Power and T.N. Wells, Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors, J Biol Chem 274 (1999), 32478-32485.
69. S. Ribeiro and R. Horuk, The clinical potential of chemokine receptor antagonists, Pharmacol Ther 107 (2005), 44-58.
70. M.J. Robertson, Role of chemokines in the biology of natural killer cells, J Leukoc Biol 71 (2002), 173-183.
71. S.C. Robinson, K.A. Scott and F.R. Balkwill, Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha, Eur J Immunol 32 (2002), 404-412.
72. S.C. Robinson, K.A. Scott, J.L. Wilson, R.G. Thompson, A.E. Proudfoot and F.R. Balkwill, A chemokine receptor antagonist inhibits experimental breast tumor growth, Cancer Res 63 (2003), 8360-8365.
73. H. Saji, M. Koike, T. Yamori, S. Saji, M. Seiki, K. Matsushima and M. Toi, Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, Cancer 92 (2001), 1085-1091.
74. R. Salcedo, M. Martins-Green, B. Gertz, J.J. Oppenheim and W.J. Murphy, Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts, Clin Cancer Res 8 (2002), 2655-2665.
75. R. Salcedo, M.L. Ponce, H.A. Young, K. Wasserman, J.M. Ward, H.K. Kleinman, J.J. Oppenheim and W.J. Murphy, Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression, Blood 96 (2000), 34-40.
76. H. Schabath, S. Runz, S. Joumaa and P. Altevogt, CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells, J Cell Sci 119 (2006), 314-325.
77. T. Schioppa, B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo and A. Sica, Regulation of the chemokine receptor CXCR4 by hypoxia, J Exp Med 198 (2003), 1391-1402.
78. S. Segerer and C.E. Alpers, Chemokines and chemokine receptors in renal pathology, Curr Opin Nephrol Hypertens 12 (2003), 243-249.
79. N. Signoret, J. Oldridge, A. Pelchen-Matthews, P.J. Klasse, T. Tran, L.F. Brass, M.M. Rosenkilde, T.W. Schwartz, W. Holmes, W. Dallas, M.A. Luther, T.N. Wells, J.A. Hoxie and M. Marsh, Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4, J Cell Biol 139 (1997), 651-664.
80. M.C. Smith, K.E. Luker, J.R. Garbow, J.L. Prior, E. Jackson, D. Piwnica-Worms and G.D. Luker, CXCR4 regulates growth of both primary and metastatic breast cancer, Cancer Res 64 (2004), 8604-8612.
81. K. Soejima and B.J. Rollins, A functional IFN-gamma-inducible protein-10/ CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan, J Immunol 167 (2001), 6576-6582.
82. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E.J. Oakeley and W. Krek, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature 425 (2003), 307-311.
83. K.A. Stormes, C.A. Lemken, J.V. Lepre, M.N. Marinucci and R.A. Kurt, Inhibition of metastasis by inhibition of tumor-derived CCL5, Breast Cancer Res Treat 89 (2005), 209-212.
84. R.M. Strieter, M.D. Burdick, J. Mestas, B. Gomperts, M.P. Keane and J.A. Belperio, Cancer CXC chemokine networks and tumour angiogenesis, Eur J Cancer 42 (2006), 768-778.
85. H. Tamamura and N. Fujii, The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis, Expert Opin Ther Targets 9 (2005), 1267-1282.
86. H. Tamamura, A. Hori, N. Kanzaki, K. Hiramatsu, M. Mizumoto, H. Nakashima, N. Yamamoto, A. Otaka and N. Fujii, T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer, FEBS Lett 550 (2003), 79-83.
87. T. Tanaka, Z. Bai, Y. Srinoulprasert, B.G. Yang, H. Hayasaka and M. Miyasaka, Chemokines in tumor progression and metastasis, Cancer Sci 96 (2005), 317-322.
88. S.T. Tarzami, R. Cheng, W. Miao, R.N. Kitsis and J.W. Berman, Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death, J Mol Cell Cardiol 34 (2002), 209-221.
89. J.P. Thiery and J.P. Sleeman, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol 7 (2006), 131-142.
90. I. Treilleux, J.Y. Blay, N. Bendriss-Vermare, I. Ray-Coquard, T. Bachelot, J.P. Guastalla, A. Bremond, S. Goddard, J.J. Pin, C. Barthelemy-Dubois and S. Lebecque, Dendritic cell infiltration and prognosis of early stage breast cancer, Clin Cancer Res 10 (2004), 7466-7474.
91. J.W. Tyner, O. Uchida, N. Kajiwara, E.Y. Kim, A.C. Patel, M.P. O'Sullivan, M.J. Walter, R.A. Schwendener, D.N. Cook, T.M. Danoff and M.J. Holtzman, CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection, Nat Med 11 (2005), 1180-1187.
92. G.G. Vaday, D.M. Peehl, P.A. Kadam and D.M. Lawrence, Expression of CCL5 (RANTES) and CCR5 in prostate cancer, Prostate 66 (2006), 124-134.
93. T.C. Walser, S. Rifat, X. Ma, N. Kundu, C. Ward, O. Goloubeva, M.G. Johnson, J.C. Medina, T.L. Collins and A.M. Fulton, Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer, Cancer Res 66 (2006), 7701-7707.
94. N. Yaal-Hahoshen, S. Shina, L. Leider-Trejo, I. Barnea, E. L. Shabtai, E. Azenshtein, I. Greenberg, I. Keydar and A. Ben-Baruch, The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients, Clin Cancer Res 12 (2006), 4474-4480.
95. S.J. Youngs, S.A. Ali, D.D. Taub and R.C. Rees, Chemokines induce migrational responses in human breast carcinoma cell lines, Int J Cancer 71 (1997), 257-266.
96. J.L. Yu and J.W. Rak, Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis, Breast Cancer Res 5 (2003), 83-88.
97. Y. Zhou, P.H. Larsen, C. Hao and V.W. Yong, CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J Biol Chem 277 (2002), 49481-49487.
98. A. Zlotnik and O. Yoshie, Chemokines: A new classification system and their role in immunity, Immunity 12 (2000), 121-127.